Unknown

Dataset Information

0

Omega-3 Fatty Acid-Type Docosahexaenoic Acid Protects against A?-Mediated Mitochondrial Deficits and Pathomechanisms in Alzheimer's Disease-Related Animal Model.


ABSTRACT: It has been reported that damage to the mitochondria affects the progression of Alzheimer's disease (AD), and that mitochondrial dysfunction is improved by omega-3. However, no animal or cell model studies have confirmed whether omega-3 inhibits AD pathology related to mitochondria deficits. In this study, we aimed to (1) identify mitigating effects of endogenous omega-3 on mitochondrial deficits and AD pathology induced by amyloid beta (A?) in fat-1 mice, a transgenic omega-3 polyunsaturated fatty acids (PUFAs)-producing animal; (2) identify if docosahexaenoic acid (DHA) improves mitochondrial deficits induced by A? in HT22 cells; and (3) verify improvement effects of DHA administration on mitochondrial deficits and AD pathology in B6SJL-Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas/Mmjax (5XFAD), a transgenic A?-overexpressing model. We found that omega-3 PUFAs significantly improved A?-induced mitochondrial pathology in fat-1 mice. In addition, our in vitro and in vivo findings demonstrate that DHA attenuated AD-associated pathologies, such as mitochondrial impairment, A? accumulation, neuroinflammation, neuronal loss, and impairment of adult hippocampal neurogenesis.

SUBMITTER: Park YH 

PROVIDER: S-EPMC7312360 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Omega-3 Fatty Acid-Type Docosahexaenoic Acid Protects against Aβ-Mediated Mitochondrial Deficits and Pathomechanisms in Alzheimer's Disease-Related Animal Model.

Park Yong Ho YH   Shin Soo Jung SJ   Kim Hyeon Soo HS   Hong Sang Bum SB   Kim Sujin S   Nam Yunkwon Y   Kim Jwa-Jin JJ   Lim Kyu K   Kim Jong-Seok JS   Kim Jin-Il JI   Jeon Seong Gak SG   Moon Minho M  

International journal of molecular sciences 20200529 11


It has been reported that damage to the mitochondria affects the progression of Alzheimer's disease (AD), and that mitochondrial dysfunction is improved by omega-3. However, no animal or cell model studies have confirmed whether omega-3 inhibits AD pathology related to mitochondria deficits. In this study, we aimed to (1) identify mitigating effects of endogenous omega-3 on mitochondrial deficits and AD pathology induced by amyloid beta (Aβ) in fat-1 mice, a transgenic omega-3 polyunsaturated fa  ...[more]

Similar Datasets

| S-EPMC2442162 | biostudies-literature
| S-EPMC10707298 | biostudies-literature
| S-EPMC4172650 | biostudies-literature
| S-EPMC19758 | biostudies-literature
| S-EPMC7001743 | biostudies-literature
| S-EPMC9866126 | biostudies-literature
| S-EPMC7191087 | biostudies-literature
| S-EPMC4054797 | biostudies-other
| S-EPMC6768642 | biostudies-literature
| S-EPMC5065772 | biostudies-literature